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Anesthetic management for aortic arch aneurysm (AAA) surgery employing deep hypothermic circulatory arrest in a 
Jehovah’s Witness (JW) patient is a challenge to anesthesiologist due to its complexity of procedures and their refusal 
of allogeneic transfusion. Even in the strict application of intraoperative acute normovolemic hemodilution (ANH) 
and intraopertive cell salvage (ICS) technique, prompt timing of re-administration of salvaged blood is essential for 
successful operation without allogeneic transfusion or ischemic complication of major organs.  Cerebral oximetery 
(rSO2) monitoring using near infrared spectroscopy is a useful modality for detecting cerebral ischemia during the 
AAA surgery requiring direct interruption of cerebral flow. The present case showed that rSO2 can be used as a trigger 
facilitating to find a better timing for the re-administration of salvaged blood acquired during the AAA surgery for JW 
patient.  (Korean J Anesthesiol 2010; 58: 191-196)
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    Because aortic arch aneurysm (AAA) surgery employing 
cardiopulmonary bypass (CBP) and deep hypothermic cardiac 
arrest (DHCA) is highly associated with massive intraoperative 
hemorrhage [1], a transfusion of allogeneic banked blood is 
required to maintain oxygen-delivery and coagulation function. 
However, since Jehovah’s witness (JW) patients refuse allogeneic 
transfusions due to their religious beliefs, intraoperative 
maintenance of these functions during AAA surgery in JW 
patients becomes complicated [2,3]. Acute normovolemic 
hemodilution (ANH) and intraoperative cell salvage (ICS) 
have been introduced for managing these patients. While 
blood retrieved from the ICS (ICS-blood) process can simply 
be reinfused with the ICS device, the blood retrieved from the 
ANH (ANH-blood) procedure can be collected only during the 
early phase of surgery, and its volume is very limited. Therefore, 
the timing and volume of ANH-blood administered should be 
carefully determined; early consumption of ANH-blood will 
make it difficult to contain the coagulation dysfunction during 
the later part of surgery and could easily be associated with 
additional hemorrhage. In contrast, insufficient or delayed 
infusion of ANH-blood may lead to excessive hemodilution 
resulting in compromised oxygen-delivery capacity and the risk 192 www.ekja.org
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for hypoxic injury. Strategies should be considered that focus 
the timing of ANH-blood administration around the time after 
weaning the patient from the CBP or around the end of the 
surgery, instead of during the mid-stage of the surgery. 
    Monitoring regional cerebral oxygen saturation (rSO2) with 
near-infrared spectroscopy mid-surgery is closely related to 
changes in intraoperative hemoglobin (Hb) levels and can 
be used as a transfusion trigger [4,5]. Intraoperative rSO2 
monitoring facilitates clinical outcome and is useful to monitor 
cerebral ischemia during cardiac surgery [6,7]. In addition to 
monitoring lactate and mixed venous oxygen saturation (SvO2), 
rSO2 monitoring provides information regarding the cerebral 
oxygen supply/consumption balance during the procedure 
of interrupting cerebral blood flow during AAA surgeries in 
JW patients and may be useful for determining the timing of 
intraoperative ANH-blood administration.
    We used rSO2 monitoring to help identify the appropriate 
time for reinfusing the limited volume of retrieved ANH- and 
ICS-blood. Then, we supplied the appropriate volume of blood 
at the appropriate times to prevent cerebral ischemia. We had 
successful anesthetic management and herein present the case.
Case Report
    A saccular aneurysm (5.3 × 4.7 × 5.0 cm) was discovered in the 
rising portion of the left carotid artery in a 36-year-old male JW 
(height, 170 cm; weight, 70 kg) (Fig. 1). The aneurysm caused 
a compression of the left (lt.) innominate artery, lt. internal 
carotid artery (ICA), and lt. subclavian artery (SCVA), as well as 
stenosis in the lt. ICA (stenosis length, 2.4 cm), so a replacement 
AAA surgery was performed. At admission, blood taken before 
the surgery showed a hematocrit (Hct) of 32%, albumin of 3.2 
g/dl, and platelets of 270,000/mm³. For a 3 day minimum, 
erythropoietin (EPO) was administered to enhance hemostasis 
before the elective surgery. However, in the repeated imaging 
tests, we found that the size of the AAA had suddenly increased, 
so the surgery could not be delayed. We preceded with the 
emergent surgery 8 h after a single subcutaneous injection of 
42,000 U EPO. 
    On the operating table, we began intraoperative monitoring 
including electrocardiography, blood pressure (BP), pulse 
oximeter (SpO2), end-tidal CO2, bispectral index, and tempe-
rature (nasophagryngeal and rectal temperature). The rSO2 
sensor (Invos
TM, Cerebral/Somatic Oximeter 5100C, Somanetics, 
Troy, MI, USA) was attached to the bilateral forehead. A right 
(rt.) radial artery cannula was placed to monitor continuous 
BP, arterial pressure waveform-derived cardiac output (APCO), 
and stroke volume variation (SVV). We performed a target-
controlled infusion of propofol and remifentanil, administered 
rocuronium, and performed an endotracheal intubation. After 
inducing anesthesia, we placed an invasive BP monitor in the 
lt. radial artery and lt. femoral artery (FA). A large-bore (9 Fr) 
central venous catheter (LB-CVC, AVA
TM, Edward Lifesciences, 
Irvine, CA, USA) and a pulmonary artery catheter was placed 
in the rt. internal jugular vein. Before surgery, we started moni-
toring continuous cardiac output, pulmonary artery pressure 
(PAP), central venous pressure (CVP), and SvO2. We placed a 
transesophageal echocardiography (TEE) probe and started 
TEE monitoring. The coagulation function was monitored by 
thromboelastometry (Rotem
TM, Pentapharm, Basel, Switzer-
land). For the ANH procedure, three closed-loops consisting 
of three-way stopcocks, intravascular lines, and three bags of 
citrate phosphate dextrose (CPD) were connected to the LB-
CVC. All loops were filled with normal saline, and continuous 
flow was maintained. Blood was withdrawn by gravity for the 
ANH. Hydroxyethylstarch (6% HES, Voluven
TM, Fresenius-Kabi, 
Fig. 1. Computed tomographic imaging 
of aortic arch aneurysm. A saccular an-
eurysm (5.3 × 4.7 × 5.0 cm) was found 
in the arising portion of the aortic 
arch’s left carotid artery and it caused a 
compression of left innominate artery, 
left internal carotid artery, and left 
subclavian arter). It also produced a 
stenosis of left internal carotid artery 
(stenosis length 2.4 cm).193 www.ekja.org
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Homborg, Germany) of the same volume was administered 
at the same rate of withdrawal. ANH (500 ml each bag, 1,500 
ml total) was retrieved and administered very slowly (<600 
ml/h) to maintain patient-bag-patient continuity. All blood 
hemorrhaged during the operation was retrieved using a cell 
salvage device (Cell Saver 6
TM, Haemonetics, Braintree, MA, 
USA). The 225-ml centrifugal container was activated in the 
automatic mode; each time 150 ml of ICS-blood was retrieved 
and reinfused. 
    Over the first half of the surgery, phenylephrine (0.01-
0.05 mcg/kg/min) was continuously administered to treat 
hypotension and vasodilation and to avoid excessive fluid 
administration resulting in red blood cell (RBC) dilution and 
worsening of the platelet and coagulation factors. When a low 
rSO2 (<50% of normal body temperature) was observed despite 
administration of ICS blood and increased phenylephrine, the 
ANH blood infusion rate was increased to restore rSO2 (Fig. 2), 
and then returned to maintenance speed immediately. 
    For the CBP, a cannula was placed in the rt. auxiliary artery 
(RAxA), FA, and superior and inferior vena cavas. After admini-
stering heparin (3 mg/kg), the activated clotting time was main-
tained for more than 400 s. A bloodless priming solution of 1,900 
ml, consisting of 100 ml of 5% albumin, 100 ml of 20% mannitol, 
500 ml of 6% HES, and the remaining crystalloid solution, 
was used to activate the CBP. Before CBP activation, 1,000 ml 
of HES and 800 ml of crystalloid solution were administered 
simultaneously to compensate for hypovolemia due to ANH. All 
blood loss from the hemorrhaging during surgery was retrieved 
entirely by ICS. We also administered 100,000 U of a urinary 
trypsin inhibitor (Ulistin
TM, Hanlim, Seoul, Korea). 
    During CBP, the mean BP was maintained at 60-70 mmHg, 
body temperature was lowered to 18°C, and tranexamic acid 
(2 g) was added to the CBP circuit. After reaching the target 
temperature, 500 mg of thiopental was administered and DHCA 
was performed for the AAA replacement procedure. 
    First, the proximal part of the lt. carotid artery (LCA) and lt. 
SCA were clamped and excised, the excised proximal part of the 
clamp was anastomosed to the prepared synthetic graft, and 
Fig. 3. Tracings of intra-operative coagulation profile using throm-
boelastometry (Rotem
TM). Top: tracing after the acute normovolemic 
hemodilution before the initiation of cardiopulmonary bypass. 
Middle: tracing at 30 min after the initiation of cardiopulmonary 
bypass. Bottom: tracing after the administration of protamine for 
heparin-reversal during post-bypass period. All tracings were made 
using heparinase cup (HEPTEM in Rotem
TM system) to remove the 
heparin’s effect on coagulation function. Reaction time, α-angle, 
were within normal range in all stages. But, the maximal amplitude 
at 30 min after the initiation of cardiopulmonary bypass was mildly 
reduced from the reference value indicated by dotted line.
Fig. 2. Schema of the intraoperative changes in cerebral oximetry 
and the timing of the autologous blood transfusion. SvO2: mixed 
venous O2 saturation, rSO2: cerebral O2 saturation measured by near 
infrared spectroscopy, ANH-blood: blood salvaged by acute normo-
volemic hemodilution, ICS-blood: blood salvaged by intraoperative 
cell-salvage procedure, CPB: cardiopulmonary bypass, DHCA: deep 
hypothermic circulatory arrest.194 www.ekja.org
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the clamp was released. The proximal and distal parts of the 
AAA and the rising part of the rt. brachiocephalic arterial trunk 
(RBCA) were clamped simultaneously. With 70-80 mmHg 
pressure on both the RAxA and FA, the CBP flow was refused 
after removal of the AAA, and both ends of the synthetic graft 
were quickly anastomosed. The anastomosis was completed 
between the clamped part of the RBCA and the synthetic graft 
branch. Then, the clamp at the proximal anastomosis of the AAA 
was released. After a 20 min interruption of cerebral flow, the 
FA-synthetic graft and both ICA connections were completed, 
cerebral perfusion was initiated, and the rewarming process was 
immediately started. Once the clamped ascending aorta was 
connected to the clamped distal anastomosis of the synthetic 
graft, both clamps were released, and normal systemic-cerebral 
circulation was completed. In addition to the priming solution, 
HES (500 ml) was also administered during the 3 h of CBP. If 
rSO2 decreased, the infusion rate of the vasoconstrictor was 
increased and the oxygen flow to the CPB oxygenator was 
reduced. At 60 min, rSO2 was reduced below 50%, 150 min after 
the start of CBP, despite the reduction in oxygen flow, and 200 
and 300 ml of ANH blood were administered (Fig. 2). After 3 h 
of CBP, the TEM showed a normal coagulation profile (Fig. 3).
    Normal body temperature recovered, the patient was weaned 
from CBP, the hemodynamics were well maintained, and the 
heparin was neutralized with protamine. After CBP weaning, 
20% mannitol (100 ml), 5% albumin (100 ml), HES (2,000 
ml), crystalloid solution (500 ml) (Plasmasol
TM, CJ, Seoul, 
Korea), and 2,800 ml of salvaged ICS blood was administered. 
Nevertheless, when rSO2 was less than 50%, the remaining 
ANH-blood was re-administered in 360 ml, 300 ml, and 300-ml 
fractions, respectively, to maintain the rCbO2 above 50%. After 
CBP, 300 ml of crystalloid was administered considering the 
excreted urine volume. 
    Over the 9 h of surgery, urine volume was maintained at 1,500 
ml and 1-2 ml/kg/h. The estimated blood loss was 3,500 ml. 
The TEM coagulation profile prior to the end of the surgery was 
normal, and the Hct was 25%. 
    The patient was transferred to the intensive care unit with 
patient-controlled analgesia and stable hemodynamic and 
coagulation function. The Hct was 26% 6 h after the surgery 
and 25% at the extubation (36 h after surgery). The Hct was 31% 
when the patient was moved to the general ward 4 days after the 
surgery. He experienced no signs of neurologic complications 
and was discharged (Table 1). 
Table 1. Perioperative Changes of Blood Chemistry Analysis
Preop
Pre-CPB CPB Post-CPB Postop
1 h 2 h  1 h 2 h 3 h 1 h 2 h 3 h 1 D 2 D 3 D 4 D
Hct (%) 32 32 33 22 17 18 20 23 25 26 25 28 31
Albumin (g/dl) 3.0 2.3 2.9 2.8 3.8
PT (sec) 16.8 17.8 12.2 18.7
PT INR 1.53 1.31 1.27
APTT (sec) 16.8 50.8 49.8 44.4
pH 7.49 7.47 7.48 7.47 7.52 7.42 7.52 7.49 7.457 7.478 7.46 7.48
PaCO2 (mmHg) 29.4 33 33 34 30 33 33 32 37 29.3 31.0 31.2
PaO2 (mmHg) 95 247 262 313 388 290 279 265 246 196 144 121
HCO3
- (mEq/L) 22.5 21.1 34.6 24.6 25.1 21 27.4 25.1 26.0 21.7 22.2 28.3
BE (mmHg) 0.5 1.5 2 1.06 2.8 -2.5 5.0 2.6 2.5 -0.8 -0.6 0.7
FiO₂ 0.6 0.5 0.6 0.6 0.6 0.35 0.3 0.3
Na
+ (mmol/L) 136 139 136 134 135 134 141 142 143 140.6 135 133
K
+ (mmol/L) 4.8 3.46 3.76 2.88 5.21 4.08 4.30 4.13 4.09 4.11 4.01 3.93
Ca
2+ (mmol/L) 0.96 1.17 1.18 1.05 1.39 1.08 1.30 1.13 1.09 1.02 1.11 1.11
Mg
2+ (mmol/L) 0.41 0.6 0.58 0.50 0.80 0.65 0.68 0.61 2.56 0.49 0.54 0.55
Lactate (mmol/L) 0.6 1.6 2.0 1.6 1.1 0.9 1.3 1.6
Glucose (mg/dl) 134 108 118 274 274 285 285 286 156 208 174
Osmorality (mOsm) 277 278 274 274 285 285 286
BUN (mg/dl) 8 9 8 9 1 9 8 8
Preop: preoperative, Postop: postoperative, Pre-CPB: period before the initiation of cardiopulmonary bypass, CPB: during the cardiopulmonary 
bypass, Post-CPB: period after the weaning from the cardiopulmonary bypass. PT: prothrombin time, APTT: activated partial thromboplastin 
time, BE: base excess, BUN: blood urea nitrogen.195 www.ekja.org
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Discussion
    The advantage of ANH is that it reduces blood viscosity. 
ANH improves microcirculation in patients in whom the blood 
viscosity increases due to severely low body temperature, as 
in the present case [8]. However, cardiovascular ischemia may 
occur if Hct decreases below a critical point (Hb 3-5 g/dl) 
[2]. In a retrospective analysis of patients who refused a blood 
transfusion for religious reasons [9], those with a Hb of 4-5 
g/dL had a 34.4% mortality rate and a 57.7% rate of serious 
side effects, such as myocardial infarction, arrhythmia, and 
cardiac failure. For every 1 g/dl reduction in Hb from 8 g/dl, the 
incidence of side effects increases 2.5 times. When Hb drops 
below 5-6 g/dl, the patient is at the highest level of danger. This 
provides a good reference point for determining the Hb/Hct 
target level during anesthetic management of a JW patient. 
    Surgeries requiring a long period of DHCA, as in the present 
case, necessitate quite a large volume of ANH blood to treat 
hemorrhaging in the latter half of the surgery. After activating 
CBP, we targeted the Hct at 20% [10] and planned to salvage 
1,800 ml of ANH blood. However, when 1,500 ml of ANH blood 
was salvaged, the rSO2 suddenly dropped below 55%. So, 
we stopped ANH (immediately after stopping ANH, the Hct 
was 22%) because we considered that a reduction below the 
absolute value of 50% or a reduction of more than 20% of the 
safe range was an abnormal symptom of rSO2 in a patient with 
carotid artery stenosis [11]. 
    Also, the possibility of exacerbated hemodilution was con-
sidered, which often occurs once CBP is activated. Moreover, 
when perfusion pressure is maintained by vasoconstrictors, as it 
was in the present case, RBCs are sequestered in the extremities, 
so rSO2 may appear rather low. In such cases, if the circulating 
blood volume is increased with fluids, one must consider that 
rSO2 could have risen despite the fact that Hct systemically 
becomes more diluted and decreases. Monitoring rSO2 may be 
more useful when a CBP circuit is activated and does not have a 
blood oxygen saturation or Hct monitor sensor attached. Even 
in the presented case, continuous rSO2 monitoring helped with 
the early discovery of sudden hemodilution. 
    We collected 1,500 ml of ANH blood in three CPD bags. The 
elapsed time from the repetition of ANH and simultaneous 
blood infusion caused dilution and a reduction in the RBC and 
plasma components. Therefore, each time ANH is performed, 
the retrieved ANH blood should be marked to identify the 
retrieval time before storage. The correct choice of ANH-blood 
among the retrieved blood fractions should be made according 
to the situation. 
    ICS washing is required due to massive hemorrhaging, which 
causes damage to plasma components (excluding RBCs) and 
exacerbates the likelihood of hemorrhaging. When all blood 
collected by ICS is completely infused, the blood salvaged last, 
which contains the lowest relative levels of Hb, platelets, and 
other coagulation factors, should be infused first. Immediately 
before the surgery ends, the ANH-blood collected at the 
beginning with relatively high content levels should be infused, 
which will help restore coagulation and hemostasis.
    Other than rSO2 monitoring, constantly monitoring circulating 
plasma and heart function by monitoring TEE, central venous 
pressure, pulmonary arterial pressure, APCO, and SVV is very 
important. In addition, determining the systemic oxygen 
supply-consumption balance by monitoring SvO2 and lactate is 
also imperative. Monitoring hemodynamics is helpful especially 
when adjusting the blood salvaging machine’s activation rate, 
the infusion rate of the retrieved ICS-blood, and the fluid 
administration rate. Determining the intravascular volume 
status is also helpful. 
    During ANH hemodilution, the intravascular protein level 
is reduced, causing changes in intravascular osmolarity, 
which causes fluid movement into the lung interstitial tissue. 
In serious cases, it results in pulmonary edema, hypoxia, and 
reduced oxygen-carrying capacity. This increases danger and 
the need for a transfusion. To prevent this, albumin, electrolytes, 
osmotic pressure, and the arterial oxygen tension/administered 
oxygen concentration ratio in the blood must be monitored and 
maintained at the beginning of surgery, as in the present case 
(Table 1). It is important not to administer crystalloid solution 
excessively. Furthermore, applying positive end-expiratory 
pressure, which can reduce pulmonary damage and protective 
ventilation, is useful.
    Administering EPO before surgery is recommended for 
increa  sing erythropoietic ability and RBC mass [3]. In the 
present case, the likelihood of AAA rupture was high and 
required emergency surgery, so it was most likely that not 
enough EPO was administered and the full effects of the 
medication were not attained.
    The use of CPB and various maneuvers during surgery cause 
inflammation and increase the likelihood of hemorrhaging. 
To prevent this, we administered transxanemic acid [12] and a 
urinary trypsin inhibitor. Although the recombinant activated 
Facto VIIa [13] is useful for successfully managing anesthesia 
in JW patients, we did not use it in the present case. Because 
the limited use of a cryoprecipitate is helpful in JW patients, its 
administration was considered for use by patient agreement 
in the presented case [13], but it was not administered due to a 
satisfactory coagulation profile. 
    In conclusion, rSO2 monitoring was useful for determining 
the timing for administering ICS- and ANH-blood when ANH 
and ICS were applied during AAA surgery in a JW patient. 196 www.ekja.org
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